A study of ghrelin and leptin levels and their relationship to metabolic profiles in obese and lean Saudi women with polycystic ovary syndrome (PCOS)

• Published in: Lipids in health and disease 2018-08, Vol.17 (1), p.195-9, Article 195
• Main Authors: Daghestani, Maha H, Daghestani, Mazin, Daghistani, Mamoon, El-Mazny, Akmal, Bjørklund, Geir, Chirumbolo, Salvatore, Al Saggaf, Samar H, Warsy, Arjumand
• Format: Article
• Language: English
• Subjects: Adult; Analysis; Body mass index; Case-Control Studies; Cholesterol; Development and progression; Female; Genetic aspects; Ghrelin; Ghrelin - blood; Gynecology; High density lipoprotein; Hip; Homeostasis; Humans; Hyperinsulinemia; Insulin; Insulin Resistance; Insulin, insulin resistance; Leptin; Leptin - blood; Low density lipoprotein; Metabolomics; Multiple regression analysis; Obesity; Obesity - blood; Obstetrics; Peptide hormones; Physiological aspects; Polycystic ovary syndrome; Polycystic Ovary Syndrome - blood; Population studies; Rodents; Saudi Arabia; Thinness - blood; Triglycerides
• ISSN: 1476-511X; 1476-511X
• DOI: 10.1186/s12944-018-0839-9

Polycystic ovary syndrome (PCOS) is considered as one of the most frequently encountered hormonal pathologies in women during their reproductive years. Leptin and ghrelin, peptide hormones with adipostatic and orexigenic effect, respectively, seem to be involved in the metabolic changes that occur in PCOS. The aim of this study was to determine serum ghrelin and leptin levels in obese and lean Saudi women with PCOS and to investigate their relationship to the metabolic profiles in these women. This study was conducted as a prospective, observational, cross-sectional, case-control study, at the Department of Obstetrics and Gynecology, Al-Noor Hospital, Makkah, Kingdom of Saudi Arabia. The study population included 252 women [130 women with PCOS (diagnosed according to the Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus, 2003) and 122 normo-ovulatory women as matched controls] attending the outpatient Gynecology Clinic. Demographic details were recorded, blood was extracted following overnight fast and serum was used for the determination of serum ghrelin and leptin levels and other hormonal and biochemical parameters including total cholesterol, triglycerides, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, glucose, and insulin. Insulin resistance and sensitivity were calculated as HOMA-IR and HOMA-S. No significant differences in ghrelin (P = 0.1830) and leptin (P = 0.8329) levels were detected between the PCOS and control groups. However, ghrelin levels were significantly lower; and leptin levels were significantly higher in obese PCOS patients in comparison with lean patients (P = 0.0001 for both). In the PCOS group, there were significant correlations between ghrelin and leptin levels with Body Mass Index (BMI), waist-hip ratio, total cholesterol, triglycerides, HDL, LDL and insulin levels. Multiple regression analysis demonstrated that insulin was the main determinant for ghrelin (R  = 0.316) and leptin (R  = 0.352) levels (P = 0.0001 for both). Although serum ghrelin and leptin levels were found to be normal in women with PCOS; yet, there is a relationship, possibly linked to obesity, hyperinsulinemia and insulin resistance between these levels and metabolic profile of Saudi PCOS.